Marla Weetall

Company: PTC Therapeutics

Job title: Senior Vice President

Seminars:

Panel Discussion: Looking Beyond Amyloid, Tau, TDP43 & Alpha Synuclein, How Can we Validate Biomarkers for Drugs with Alternative Mechanisms? 3:00 pm

Evaluating how these markers are for TDP43 & Alpha Synuclein across disease? Exploring use cases of biomarker usage for neuroinflammatory pathology, microglia and oxidative stress where there is little relevance to the disease indication Navigating future directions to improve ease of biomarker utility in drug developmentRead more

day: Conference Day 2

Monitoring Changes of RNA & Protein in the Blood as a Surrogate Measure for Changes in Monogenetic Disorders in the CNS 2:30 pm

Case studies Biological confirmation in animal models Considerations in developing clinical grade assays to demonstrate target engagementRead more

day: Conference Day 2